|
π
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
49 auth.
J. Smolen,
R. LandewΓ©,
J. Bijlsma,
G. Burmester,
K. Chatzidionysiou,
M. Dougados,
J. Nam,
S. Ramiro,
M. Voshaar,
R. V. van Vollenhoven,
D. Aletaha,
M. Aringer,
M. Boers,
C. Buckley,
F. Buttgereit,
...
V. Bykerk,
M. Cardiel,
B. Combe,
M. Cutolo,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
C. Gabay,
J. GΓ³mez-Reino,
L. Gossec,
J. Gottenberg,
J. Hazes,
T. Huizinga,
M. Jani,
D. Karateev,
M. Kouloumas,
T. Kvien,
Zhanguo Li,
X. Mariette,
I. McInnes,
E. Mysler,
P. Nash,
K. Pavelka,
G. PoΓ³r,
C. Richez,
P. V. van Riel,
A. Rubbert-Roth,
K. Saag,
J. D. da Silva,
T. Stamm,
T. Takeuchi,
R. Westhovens,
M. D. de Wit,
D. M. van der Heijde
|
11 |
2010 |
11
π
|
|
π
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
47 auth.
J. Smolen,
R. LandewΓ©,
J. Bijlsma,
G. Burmester,
M. Dougados,
A. Kerschbaumer,
I. McInnes,
A. Sepriano,
R. V. van Vollenhoven,
M. D. de Wit,
D. Aletaha,
M. Aringer,
J. Askling,
A. Balsa,
M. Boers,
...
A. D. den Broeder,
M. Buch,
F. Buttgereit,
R. Caporali,
M. Cardiel,
D. De Cock,
C. Codreanu,
M. Cutolo,
C. Edwards,
Y. van Eijk-Hustings,
P. Emery,
A. Finckh,
L. Gossec,
J. Gottenberg,
M. Hetland,
T. Huizinga,
Marios Koloumas,
Zhanguo Li,
X. Mariette,
U. MuΜller-Ladner,
E. Mysler,
J. D. da Silva,
G. PoΓ³r,
J. Pope,
A. Rubbert-Roth,
A. Ruyssen-witrand,
K. Saag,
A. Strangfeld,
T. Takeuchi,
M. Voshaar,
R. Westhovens,
D. M. van der Heijde
|
10 |
2020 |
10
π
|
|
π
|
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
48 auth.
J. Smolen,
R. LandewΓ©,
S. Bergstra,
A. Kerschbaumer,
A. Sepriano,
D. Aletaha,
R. Caporali,
C. Edwards,
K. Hyrich,
J. Pope,
Savia de Souza,
T. Stamm,
T. Takeuchi,
P. Verschueren,
K. Winthrop,
...
A. Balsa,
J. Bathon,
M. Buch,
G. Burmester,
F. Buttgereit,
M. Cardiel,
K. Chatzidionysiou,
C. Codreanu,
M. Cutolo,
A. D. den Broeder,
K. El Aoufy,
A. Finckh,
J. Fonseca,
J. Gottenberg,
E. Haavardsholm,
A. Iagnocco,
K. Lauper,
Zhanguo Li,
I. McInnes,
E. Mysler,
P. Nash,
G. PoΓ³r,
G. RistiΔ,
F. Rivellese,
A. Rubbert-Roth,
H. Schulze-Koops,
N. Stoilov,
Anja Strangfeld,
A. H. M. van der Helm-van Mil,
E. van Duuren,
T. V. Vliet Vlieland,
R. Westhovens,
D. M. van der Heijde
|
9 |
2022 |
9
π
|
|
π
|
Circulating precursor CCR7(lo)PD-1(hi) CXCR5βΊ CD4βΊ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure.
32 auth.
Jing He,
Louis M. Tsai,
Y. A. Leong,
Xinju Hu,
Xinju Hu,
Cindy S. Ma,
Cindy S. Ma,
N. Chevalier,
N. Chevalier,
Xiaolin Sun,
K. Vandenberg,
S. Rockman,
Yan Ding,
Lei Zhu,
Wei Wei,
...
Changqi Wang,
A. Karnowski,
G. Belz,
Joanna R. Ghali,
M. Cook,
S. Riminton,
A. Veillette,
P. Schwartzberg,
F. Mackay,
R. Brink,
R. Brink,
S. Tangye,
S. Tangye,
C. Vinuesa,
C. Mackay,
Zhanguo Li,
Di Yu
|
9 |
2013 |
9
π
|
|
π’
|
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
32 auth.
Jing He,
Xia Zhang,
Yunbo Wei,
Xiaolin Sun,
Yaping Chen,
Jun Deng,
Yuebo Jin,
Y. Gan,
Xin Hu,
R. Jia,
Chuanhui Xu,
Zhaohua Hou,
Y. A. Leong,
Lei Zhu,
Jinhong Feng,
...
Y. An,
Yuan Jia,
Chun Li,
Xu Liu,
H. Ye,
L. Ren,
Ru Li,
H. Yao,
Yu-hui Li,
Shi Chen,
Xuewu Zhang,
Yin Su,
Jianping Guo,
N. Shen,
E. Morand,
Di Yu,
Zhanguo Li
|
8 |
2016 |
8
π’
|
|
π’
|
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
31 auth.
Jing He,
Ruijun Zhang,
M. Shao,
Xiaozhen Zhao,
M. Miao,
Jiali Chen,
Jiajia Liu,
Xiaoying Zhang,
Xia Zhang,
Yuebo Jin,
Yu Wang,
Shilei Zhang,
Lei Zhu,
A. Jacob,
R. Jia,
...
X. You,
Xue Li,
Chun Li,
Yunshan Zhou,
Yue Yang,
H. Ye,
Yanying Liu,
Yin Su,
N. Shen,
J. Alexander,
Jianping Guo,
J. Ambrus,
Xin Lin,
Di Yu,
Xiaolin Sun,
Zhanguo Li
|
7 |
2019 |
7
π’
|
|
π
|
Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population
9 auth.
Xu-jie Zhou,
Xiao-lan Lu,
J. Lv,
Hai-zhen Yang,
L. Qin,
Ming-hui Zhao,
...
Yin Su,
Zhanguo Li,
Hong Zhang
|
7 |
2011 |
7
π
|
|
π’
|
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
19 auth.
Yanying Liu,
R. Mu,
Shi-yao Wang,
L. Long,
Xia Liu,
Ru Li,
Jian Sun,
Jianping Guo,
Xiaoping Zhang,
Jing Guo,
...
P. Yu,
Chunlei Li,
Xiangyuan Liu,
Zhen Huang,
Dapeng Wang,
Hu Li,
Z. Gu,
Bing Liu,
Zhanguo Li
|
7 |
2010 |
7
π’
|
|
π’
|
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing.
20 auth.
Ru Li,
Jian Sun,
L. Ren,
Hong-yu Wang,
Wen-Hong Liu,
Xue-wu Zhang,
Shi Chen,
R. Mu,
Jing He,
Yi Zhao,
...
L. Long,
Yanying Liu,
Xia Liu,
Xiao-lan Lu,
Yu-hui Li,
Shi-yao Wang,
Si-Si Pan,
Chun Xing Li,
Hong-yuan Wang,
Zhanguo Li
|
7 |
2012 |
7
π’
|
|
π’
|
Circulating Dickkopf-1 Is Correlated with Bone Erosion and Inflammation in Rheumatoid Arthritis
7 auth.
Shi-yao Wang,
Yanying Liu,
H. Ye,
Jianping Guo,
Ru Li,
Xia Liu,
...
Zhanguo Li
|
7 |
2011 |
7
π’
|
|
π
|
Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis
13 auth.
Chunqing Guo,
F. Hu,
H. Yi,
Zhitao Feng,
Changzheng Li,
Lianjie Shi,
Yingni Li,
Hongjiang Liu,
Xiaofei Yu,
Hongxia Wang,
...
Juan Li,
Zhanguo Li,
Xiang-Yang Wang
|
7 |
2014 |
7
π
|
|
π
|
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases
25 auth.
Jian Zhao,
Jianyang Ma,
Yun Deng,
J. Kelly,
Kwangwoo Kim,
S. Bang,
Hye-Soon Lee,
Quanzhen Li,
E. Wakeland,
Rong Qiu,
Meng-ru Liu,
Jianping Guo,
Zhanguo Li,
W. Tan,
A. Rasmussen,
...
C. Lessard,
K. Sivils,
B. Hahn,
J. Grossman,
D. Kamen,
G. Gilkeson,
S. Bae,
P. Gaffney,
N. Shen,
B. Tsao
|
7 |
2017 |
7
π
|
